BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9558172)

  • 1. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.
    Uesugi H; Ozaki S; Sobajima J; Osakada F; Shirakawa H; Yoshida M; Nakao K
    J Rheumatol; 1998 Apr; 25(4):703-9. PubMed ID: 9558172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis.
    Sobajima J; Ozaki S; Uesugi H; Osakada F; Inoue M; Fukuda Y; Shirakawa H; Yoshida M; Rokuhara A; Imai H; Kiyosawa K; Nakao K
    Gut; 1999 Jun; 44(6):867-73. PubMed ID: 10323891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC).
    Sobajima J; Ozaki S; Uesugi H; Osakada F; Shirakawa H; Yoshida M; Nakao K
    Clin Exp Immunol; 1998 Feb; 111(2):402-7. PubMed ID: 9486411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of anti-neutrophil cytoplasmic antibodies in MRL/Mp-lpr/lpr mice and analysis of their target antigens.
    Ma W; Ozaki S; Sobajima J; Uesugi H; Murakami M; Tanaka M; Kozuki M; Hashimoto H; Fujita Y; Kawabata D; Osakada F; Shirakawa H; Yoshida M; Hayami M; Nakao K
    Autoimmunity; 2000 Dec; 32(4):281-91. PubMed ID: 11191287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA.
    Gripenberg M; Helve T; Kurki P
    J Rheumatol; 1985 Oct; 12(5):934-9. PubMed ID: 3878880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules.
    Chen M; Zhao MH; Zhang YK; Wang HY
    Nephrology (Carlton); 2005 Oct; 10(5):491-5. PubMed ID: 16221101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.
    Khanna D; Aggarwal A; Bhakuni DS; Dayal R; Misra R
    J Rheumatol; 2003 Jun; 30(6):1248-52. PubMed ID: 12784398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2.
    Sobajima J; Ozaki S; Osakada F; Uesugi H; Shirakawa H; Yoshida M; Nakao K
    Clin Exp Immunol; 1997 Jan; 107(1):135-40. PubMed ID: 9010268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of the anti-Ro(SSA) response in rheumatic diseases.
    López-Longo FJ; Rodríguez-Mahou M; Escalona M; Pérez T; Monteagudo I; Sánchez-Atrio A; Grau R; González C; Moreno AC; Carreño L
    J Rheumatol; 1994 Aug; 21(8):1450-6. PubMed ID: 7983645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontitis and anti-neutrophil cytoplasmic antibodies in systemic lupus erythematosus and rheumatoid arthritis: a comparative study.
    Novo E; Garcia-MacGregor E; Viera N; Chaparro N; Crozzoli Y
    J Periodontol; 1999 Feb; 70(2):185-8. PubMed ID: 10102556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
    Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
    Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
    J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.